CTBO

Cantabio Pharmaceuticals, Inc. CTBO

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CTBO HGENQ NPTX DGCRF QSAM TTBLF NLBS RTSL GNBT NMDBF
6M 0.00 % 100.00 % 50.00 % 0.00 % 18.57 % -98.33 % 0.00 % -67.14 % -40.00 % 0.00 %
YTD 0.00 % -84.62 % 50.00 % 0.00 % 36.07 % -98.35 % 0.00 % 15.00 % 0.00 % 0.00 %
1Y 0.00 % -98.78 % -98.50 % 0.00 % 74.74 % -99.33 % -50.00 % 130.00 % -99.13 % -88.40 %
3Y 0.00 % -100.00 % -99.97 % 9 900.00 % -43.92 % -99.93 % -99.88 % -99.85 % -99.89 % -88.40 %
5Y -95.96 % -100.00 % -99.98 % 0.00 % 1 409.09 % -99.99 % -99.89 % -99.73 % -99.51 % -88.40 %
10Y -99.99 % -100.00 % -99.98 % -99.91 % -99.60 % -99.99 % -99.98 % -99.85 % -99.60 % -88.40 %
From the beginning -99.99 % -100.00 % -99.98 % -99.99 % -99.97 % -99.99 % -99.99 % -99.85 % -99.60 % -88.40 %

Dividend

Diagnocure, Inc.